Recto, Analyn .

HRN: 22-59-21  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/15/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/15/2023
02/22/2023
IV
500 Mg
Every 8 Hours
Thinly Meconium-Stained Amniotic Fluid
Waiting Final Action 
02/15/2023
CEFUROXIME 1.5GM (VIAL)
02/15/2023
02/15/2023
IV
1.5 Grams
Now
Thinly Meconium-Stained Amniotic Fluid
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: